ArriVent BioPharma Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 05/15/2026 | 4.40 M | $101.53 M | 7.19% | 11.44% |
| INFINITUM ASSET MANAGEMENT, LLC | 05/15/2026 | 4.15 M | $95.72 M | 0.61% | 10.79% |
| HHLR ADVISORS, LTD. | 05/15/2026 | 3.93 M | $90.64 M | 0.00% | 10.22% |
| ORBIMED ADVISORS LLC | 05/15/2026 | 3.03 M | $69.84 M | 0.00% | 7.87% |
| FMR LLC | 05/15/2026 | 3.02 M | $69.58 M | -18.56% | 7.84% |
| BLACKROCK, INC. | 05/13/2026 | 2.53 M | $58.37 M | 6.64% | 6.58% |
| OCTAGON CAPITAL ADVISORS LP | 05/15/2026 | 1.97 M | $45.47 M | 0.00% | 5.12% |
| NOVO HOLDINGS A/S | 05/15/2026 | 1.94 M | $44.81 M | 0.00% | 5.05% |
| SOFINNOVA INVESTMENTS, INC. | 05/15/2026 | 1.70 M | $39.14 M | 0.00% | 4.41% |
| 05/15/2026 | 1.53 M | $35.27 M | 100.00% | 3.98% | |
| GENERAL CATALYST GROUP MANAGEMENT, LLC | 05/15/2026 | 1.49 M | $34.48 M | 0.00% | 3.89% |
| STATE STREET CORP | 05/15/2026 | 1.42 M | $32.79 M | 30.17% | 3.70% |
| VIVO CAPITAL, LLC | 05/20/2026 | 885.92 K | $20.44 M | 100.00% | 2.30% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 853.43 K | $19.69 M | 14.94% | 2.22% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 803.65 K | $18.54 M | 6.65% | 2.09% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 748.20 K | $17.26 M | 245.33% | 1.95% |
| SC CHINA HOLDING LTD | 05/15/2026 | 663.31 K | $13.98 M | 0.00% | 1.72% |
| FUND 1 INVESTMENTS, LLC | 05/15/2026 | 499.99 K | $11.53 M | -11.64% | 1.30% |
| UBS GROUP AG | 05/05/2026 | 486.26 K | $11.22 M | 7.84% | 1.26% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2026 | 426.28 K | $9.83 M | 890.66% | 1.11% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 425.92 K | $9.83 M | 51.06% | 1.11% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 368.80 K | $8.51 M | 58.06% | 0.96% |
| LOGOS GLOBAL MANAGEMENT LP | 05/15/2026 | 350.00 K | $8.07 M | 100.00% | 0.91% |
| NORTHERN TRUST CORP | 05/14/2026 | 268.81 K | $6.20 M | 9.45% | 0.70% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 258.77 K | $5.97 M | 3.27% | 0.67% |
| 05/08/2026 | 253.85 K | $5.86 M | 100.00% | 0.66% | |
| NOMURA HOLDINGS INC | 05/15/2026 | 242.05 K | $5.58 M | 100.00% | 0.63% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 217.13 K | $5.01 M | 100.00% | 0.56% |
| AMERIPRISE FINANCIAL INC | 05/15/2026 | 180.03 K | $4.15 M | 51.94% | 0.47% |
| AFFINITY ASSET ADVISORS, LLC | 05/14/2026 | 175.00 K | $4.04 M | 16.67% | 0.46% |
| CITADEL ADVISORS LLC | 05/15/2026 | 166.16 K | $3.83 M | -63.76% | 0.43% |
| CITADEL ADVISORS LLC | 05/15/2026 | 161.30 K | $3.72 M | 100.00% | 0.42% |
| WOODLINE PARTNERS LP | 05/15/2026 | 147.64 K | $3.41 M | 0.17% | 0.38% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/18/2026 | 141.81 K | $3.27 M | 100.00% | 0.37% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 131.00 K | $3.02 M | 100.00% | 0.34% |
| MORGAN STANLEY | 05/15/2026 | 128.55 K | $2.97 M | 31.72% | 0.33% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 126.53 K | $2.92 M | 758.20% | 0.33% |
| POLYMER CAPITAL MANAGEMENT (HK) LTD | 05/14/2026 | 122.28 K | $2.82 M | 100.00% | 0.32% |
| 05/15/2026 | 110.00 K | $2.54 M | 100.00% | 0.29% | |
| BURKEHILL GLOBAL MANAGEMENT, LP | 05/15/2026 | 100.00 K | $2.31 M | 0.00% | 0.26% |
| E FUND MANAGEMENT CO., LTD. | 04/13/2026 | 93.95 K | $2.17 M | 100.00% | 0.24% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 80.21 K | $1.85 M | 41.91% | 0.21% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/15/2026 | 78.21 K | $1.80 M | -4.94% | 0.20% |
| BANK OF NEW YORK MELLON CORP | 05/05/2026 | 75.45 K | $1.74 M | 3.20% | 0.20% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 70.32 K | $1.62 M | 100.00% | 0.18% |
| JPMORGAN CHASE & CO | 05/13/2026 | 65.88 K | $1.38 M | -5.07% | 0.17% |
| BARCLAYS PLC | 05/15/2026 | 65.41 K | $1.51 M | -49.36% | 0.17% |
| XTX TOPCO LTD | 05/15/2026 | 63.00 K | $1.45 M | 139.98% | 0.16% |
| NUVEEN, LLC | 04/30/2026 | 56.84 K | $1.31 M | 6.01% | 0.15% |
| MOODY ALDRICH PARTNERS LLC | 04/20/2026 | 56.09 K | $1.29 M | -1.01% | 0.15% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ArriVent BioPharma Inc. institutional Ownership - FAQ's
During the previous two years, 152 institutional investors and hedge funds held shares of ArriVent BioPharma Inc.. The most heavily invested institutionals were:
SUVRETTA CAPITAL MANAGEMENT, LLC: 4.4 M
INFINITUM ASSET MANAGEMENT, LLC: 4.15 M
HHLR ADVISORS, LTD.: 3.93 M
ORBIMED ADVISORS LLC: 3.03 M
FMR LLC: 3.02 M
BlackRock, Inc.: 2.53 M
109.72% of ArriVent BioPharma Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 43.38 M shares in the last 24 months. This purchase volume represents approximately $1.08 B in transactions.